Artificial Intelligence Enhances Blood Pressure Reporting Accuracy in Older Adults at Home

AI-powered voice assistants are transforming blood pressure management among older adults by enabling accurate self-reporting, improving outcomes, and reducing costs. Learn how this innovative technology is changing hypertension care.
Recent research presented at the American Heart Association's Hypertension Scientific Sessions 2025 highlights the promising role of artificial intelligence (AI) voice assistants in improving blood pressure monitoring among older adults. The study focused on how AI-powered voice agents can facilitate accurate self-reporting of blood pressure measurements, a crucial factor in managing hypertension and preventing cardiovascular complications.
The study involved 2,000 adults, predominantly aged 65 and above, all receiving care for high blood pressure. Researchers leveraged AI voice agents that interacted with patients in multiple languages, including English and Spanish, to prompt them for blood pressure readings and assist in recording the data into electronic health records (EHR). These AI interactions aimed to bridge gaps in care caused by limited access to healthcare providers and ensure timely, precise blood pressure monitoring.
Lead researcher Dr. Tina-Ann Kerr Thompson explained, "Controlling blood pressure remains essential for reducing cardiovascular risks, but collecting accurate and timely readings is often challenging. Our study demonstrates that AI voice assistants can significantly improve measurement accuracy and patient engagement." The system also identified patients needing urgent follow-up based on their blood pressure levels, escalating calls to healthcare professionals when necessary.
The AI calls not only aimed to gather recent blood pressure data but also involved live measurements during interactions. The process allowed clinicians to review the information, improve clinical workflows, and reduce manual workload. The study revealed an impressive reduction in costs—an 88.7% decrease per blood pressure reading—by replacing some human-led calls with AI interactions.
During the study period, 85% of patients were successfully contacted, with 67% completing the call, and 60% providing compliant blood pressure readings. Among these, 68% achieved recommended blood pressure control standards. Patient satisfaction was notably high, with average scores above 9 out of 10, reflecting positive engagement with the AI system.
Experts like Eugene Yang from the University of Washington consider this a potential game-changer. He emphasized that advances in AI technology could revolutionize blood pressure management, especially in underserved populations, by making accurate monitoring more accessible and addressing barriers like limited provider contact.
However, the study’s limitations include its observational nature without a control group. AI calls were deployed because the required volume of human-only calls was not feasible, and the retrospective analysis reviewed existing data. Despite these constraints, findings suggest AI integration can enhance patient outcomes and healthcare efficiency.
The research aligns with initiatives like Target:BP, promoting home blood pressure monitoring as recommended by current guidelines. The findings support the growing role of AI in healthcare, emphasizing its capacity to improve hypertension management and ultimately, cardiovascular health.
For more details, visit source: https://medicalxpress.com/news/2025-09-ai-older-adults-accurate-blood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Non-Invasive Ultrasound Test Promises Accurate Diagnosis of Infant Meningitis
A new high-resolution ultrasound device offers a non-invasive, accurate method for detecting meningitis in infants, potentially transforming pediatric diagnostics worldwide.
Europe Faces Record Surge in Mosquito-Borne Disease Outbreaks Amid Climate Change
Europe reports a record number of mosquito-borne disease outbreaks in 2025, driven by climate change. Learn about the rising risks and preventive measures.
Clinical Trial Finds Osimertinib Combined with Chemotherapy Extends Survival in EGFR-Mutated Advanced Lung Cancer
A groundbreaking Phase III trial demonstrates that combining osimertinib with chemotherapy significantly extends overall survival in patients with EGFR-mutated advanced lung cancer, potentially establishing a new standard of care.



